Elevated Fra-1 expression causes severe lipodystrophy

Journal of Cell Science

Volumn 124, Issue 9, 2011, Pages 1465-1476

  Luther, Julia ^a,b   Driessler, Frank ^b,e   Megges, Matthias ^b   Hess, Andreas ^a   Herbort, Bettina ^a   Mandic, Vice ^b,f   Zaiss, Mario M ^a   Reichardt, Anne ^b   Zech, Christine ^a,b   Tuckermann, Jan P ^c   Calkhoven, Cornelis F ^c   Wagner, Erwin F ^d   Schett, Georg ^a   David, Jean Pierre ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b DEUTSCHES RHEUMA FORSCHUNGSZENTRUM   (Germany)

^c FRITZ LIPMANN INSTITUTE   (Germany)

^d Centro Nacional de Investigations Oncológicas   (Spain)

^e GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^f SHRINERS HOSPITAL FOR CHILDREN   (Canada)

Author keywords

Adipocytes; AP 1; Bone; C EBP ; Fra 1

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CD36 ANTIGEN; FATTY ACID; FATTY ACID TRANSPORTER; TRANSCRIPTION FACTOR FRA 1; TRIACYLGLYCEROL;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; CELL DIFFERENTIATION; CONTROLLED STUDY; DIET RESTRICTION; DOWN REGULATION; FATTY ACID BLOOD LEVEL; FEMALE; LIPODYSTROPHY; MALE; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSCLEROSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOCYTES; ADIPOGENESIS; ANIMALS; ANTIGENS, CD36; BLOTTING, WESTERN; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CHROMATIN IMMUNOPRECIPITATION; IMMUNOPRECIPITATION; LIPODYSTROPHY; MAGNETIC RESONANCE IMAGING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; OSTEOBLASTS; OSTEOGENESIS; POLYMERASE CHAIN REACTION; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS;

MUS; MUS MUSCULUS;

EID: 79955531027     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.079855     Document Type: Article

References (51)

1. Abbott, D. W. and Holt, J. T. (1997). Finkel-Biskis-Reilly osteosarcoma virus v-Fos inhibits adipogenesis and both the activity and expression of CCAAT/enhancer binding protein alpha, a key regulator of adipocyte differentiation. J. Biol. Chem. 272, 32454-32462.
2. Cao, Z., Umek, R. M. and McKnight, S. L. (1991). Regulated expression of three C/EBP isoforms during adipose conversion of 3T3-L1 cells. Genes Dev. 5, 1538-1552.
3. Caplan, A. I. (2007). Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J. Cell. Physiol. 213, 341-347.
4. David, J. P., Neff, L., Chen, Y., Rincon, M., Horne, W. C. and Baron, R. (1998). A new method to isolate large numbers of rabbit osteoclasts and osteoclast-like cells: application to the characterization of serum response element binding proteins during osteoclast differentiation. J. Bone Miner. Res. 13, 1730-1738.
5. David, J. P., Sabapathy, K., Hoffmann, O., Idarraga, M. H. and Wagner, E. F. (2002). JNK1 modulates osteoclastogenesis through both c-Jun phosphorylation-dependent and -independent mechanisms. J. Cell Sci. 115, 4317-4325.
6. Ducy, P., Amling, M., Takeda, S., Priemel, M., Schilling, A. F., Beil, F. T., Shen, J., Vinson, C., Rueger, J. M. and Karsenty, G. (2000). Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100, 197-207.
7. Eferl, R. and Wagner, E. F. (2003). AP-1: a double-edged sword in tumorigenesis. Nat. Rev. Cancer 3, 859-868.
8. Eferl, R., Hoebertz, A., Schilling, A. F., Rath, M., Karreth, F., Kenner, L., Amling, M. and Wagner, E. F. (2004). The Fos-related antigen Fra-1 is an activator of bone matrix formation. EMBO J. 23, 2789-2799.
9. Febbraio, M., Abumrad, N. A., Hajjar, D. P., Sharma, K., Cheng, W., Pearce, S. F. and Silverstein, R. L. (1999). A null mutation in murine CD36 reveals an important role in fatty acid and lipoprotein metabolism. J. Biol. Chem. 274, 19055-19062.
10. Ferron, M., Wei, J., Yoshizawa, T., Del Fattore, A., DePinho, R. A., Teti, A., Ducy, P. and Karsenty, G. (2010). Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 142, 296-308.
11. Fulzele, K., Riddle, R. C., DiGirolamo, D. J., Cao, X., Wan, C., Chen, D., Faugere, M. C., Aja, S., Hussain, M. A., Bruning, J. C. et al. (2010). Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 142, 309-319.
12. Gesta, S., Tseng, Y. H. and Kahn, C. R. (2007). Developmental origin of fat: tracking obesity to its source. Cell 131, 242-256.
13. Grigoriadis, A. E., Schellander, K., Wang, Z. Q. and Wagner, E. F. (1993). Osteoblasts are target cells for transformation in c-fos transgenic mice. J. Cell Biol. 122, 685-701.
14. Guth, S. I., Schmidt, K., Hess, A. and Wegner, M. (2009). Adult-onset degeneration of adipose tissue in mice deficient for the Sox8 transcription factor. J. Lipid Res. 50, 1269-1280.
15. Hinoi, E., Gao, N., Jung, D. Y., Yadav, V., Yoshizawa, T., Myers, M. G., Jr, Chua, S. C., Jr, Kim, J. K., Kaestner, K. H. and Karsenty, G. (2008). The sympathetic tone mediates leptin's inhibition of insulin secretion by modulating osteocalcin bioactivity. J. Cell Biol. 183, 1235-1242.
16. Jochum, W., David, J. P., Elliott, C., Wutz, A., Plenk, H., Jr, Matsuo, K. and Wagner, E. F. (2000). Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6, 980-984.
17. Karsenty, G. (2008). Transcriptional control of skeletogenesis. Annu. Rev. Genomics Hum. Genet. 9, 183-196.
18. Kawamata, A., Izu, Y., Yokoyama, H., Amagasa, T., Wagner, E. F., Nakashima, K., Ezura, Y., Hayata, T. and Noda, M. (2008). JunD suppresses bone formation and contributes to low bone mass induced by estrogen depletion. J. Cell. Biochem. 103, 1037-1045.
19. Kenner, L., Hoebertz, A., Beil, T., Keon, N., Karreth, F., Eferl, R., Scheuch, H., Szremska, A., Amling, M., Schorpp-Kistner, M. et al. (2004). Mice lacking JunB are osteopenic due to cell-autonomous osteoblast and osteoclast defects. J. Cell Biol. 164, 613-623.
20. Komori, T. (2006). Regulation of osteoblast differentiation by transcription factors. J. Cell. Biochem. 99, 1233-1239.
21. Kveiborg, M., Chiusaroli, R., Sims, N. A., Wu, M., Sabatakos, G., Horne, W. C. and Baron, R. (2002). The increased bone mass in deltaFosB transgenic mice is independent of circulating leptin levels. Endocrinology 143, 4304-4309.
22. Kveiborg, M., Sabatakos, G., Chiusaroli, R., Wu, M., Philbrick, W. M., Horne, W. C. and Baron, R. (2004). DeltaFosB induces osteosclerosis and decreases adipogenesis by two independent cell-autonomous mechanisms. Mol. Cell. Biol. 24, 2820-2830.
23. Lee, N. K. and Karsenty, G. (2008). Reciprocal regulation of bone and energy metabolism. Trends Endocrinol. Metab. 19, 161-166.
24. Lee, N. K., Sowa, H., Hinoi, E., Ferron, M., Ahn, J. D., Confavreux, C., Dacquin, R., Mee, P. J., McKee, M. D., Jung, D. Y. et al. (2007). Endocrine regulation of energy metabolism by the skeleton. Cell 130, 456-469.
25. Lefterova, M. I. and Lazar, M. A. (2009). New developments in adipogenesis. Trends Endocrinol. Metab. 20, 107-114.
26. Lieben, L., Callewaert, F. and Bouillon, R. (2009). Bone and metabolism: a complex crosstalk. Horm. Res. 71 Suppl. 1, 134-138.
27. Linhart, H. G., Ishimura-Oka, K., DeMayo, F., Kibe, T., Repka, D., Poindexter, B., Bick, R. J. and Darlington, G. J. (2001). C/EBPalpha is required for differentiation of white, but not brown, adipose tissue. Proc. Natl. Acad. Sci. USA 98, 12532-12537.
28. Moitra, J., Mason, M. M., Olive, M., Krylov, D., Gavrilova, O., Marcus-Samuels, B., Feigenbaum, L., Lee, E., Aoyama, T., Eckhaus, M. et al. (1998). Life without white fat: a transgenic mouse. Genes Dev. 12, 3168-3181.
29. Plum, L., Rother, E., Munzberg, H., Wunderlich, F. T., Morgan, D. A., Hampel, B., Shanabrough, M., Janoschek, R., Konner, A. C., Alber, J. et al. (2007). Enhanced leptin-stimulated Pi3k activation in the CNS promotes white adipose tissue transdifferentiation. Cell Metab. 6, 431-445.
30. Qiao, L. P., Zou, C. H., Shao, P., Schaack, J., Johnson, P. F. and Shao, J. H. (2008). Transcriptional regulation of fatty acid Translocase/CD36 expression by CCAAT/Enhancer-binding protein alpha. J. Biol. Chem. 283, 8788-8795.
31. Rosen, C. J. (2008). Bone remodeling, energy metabolism, and the molecular clock. Cell Metab. 7, 7-10.
32. Rosen, E. D. and MacDougald, O. A. (2006). Adipocyte differentiation from the inside out. Nat. Rev. Mol. Cell Biol. 7, 885-896.
33. Rowe, G. C., Choi, C. S., Neff, L., Horne, W. C., Shulman, G. I. and Baron, R. (2009). Increased energy expenditure and insulin sensitivity in the high bone mass DeltaFosB transgenic mice. Endocrinology 150, 135-143.
34. Sabatakos, G., Sims, N. A., Chen, J., Aoki, K., Kelz, M. B., Amling, M., Bouali, Y., Mukhopadhyay, K., Ford, K., Nestler, E. J. et al. (2000). Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6, 985-990.
35. Schmidt, K., Schinke, T., Haberland, M., Priemel, M., Schilling, A. F., Mueldner, C., Rueger, J. M., Sock, E., Wegner, M. and Amling, M. (2005). The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J. Cell Biol. 168, 899-910.
36. Shi, X., Shi, W., Li, Q., Song, B., Wan, M., Bai, S. and Cao, X. (2003). A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4, 374-380.
37. Shi, Y., Yadav, V. K., Suda, N., Liu, X. S., Guo, X. E., Myers, M. G., Jr and Karsenty, G. (2008). Dissociation of the neuronal regulation of bone mass and energy metabolism by leptin in vivo. Proc. Natl. Acad. Sci. USA 105, 20529-20533.
38. Shimomura, I., Hammer, R. E., Richardson, J. A., Ikemoto, S., Bashmakov, Y., Goldstein, J. L. and Brown, M. S. (1998). Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12, 3182-3194.
39. Takada, I., Suzawa, M., Matsumoto, K. and Kato, S. (2007). Suppression of PPAR transactivation switches cell fate of bone marrow stem cells from adipocytes into osteoblasts. Ann. N. Y. Acad. Sci. 1116, 182-195.
40. Takeda, S., Elefteriou, F., Levasseur, R., Liu, X., Zhao, L., Parker, K. L., Armstrong, D., Ducy, P. and Karsenty, G. (2002). Leptin regulates bone formation via the sympathetic nervous system. Cell 111, 305-317.
41. Tsukiyama-Kohara, K., Poulin, F., Kohara, M., DeMaria, C. T., Cheng, A., Wu, Z., Gingras, A. C., Katsume, A., Elchebly, M., Spiegelman, B. M. et al. (2001). Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1. Nat. Med. 7, 1128-1132.
42. Wagner, E. F. and Eferl, R. (2005). Fos/AP-1 proteins in bone and the immune system. Immunol. Rev. 208, 126-140.
43. Wang, N. D., Finegold, M. J., Bradley, A., Ou, C. N., Abdelsayed, S. V., Wilde, M. D., Taylor, L. R., Wilson, D. R. and Darlington, G. J. (1995). Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269, 1108-1112.
44. Weinstock, P. H., Bisgaier, C. L., Aalto-Setala, K., Radner, H., Ramakrishnan, R., Levak-Frank, S., Essenburg, A. D., Zechner, R. and Breslow, J. L. (1995). Severe hypertriglyceridemia, reduced high density lipoprotein, and neonatal death in lipoprotein lipase knockout mice. Mild hypertriglyceridemia with impaired very low density lipoprotein clearance in heterozygotes. J. Clin. Invest. 96, 2555-2568.
45. White, U. A. and Stephens, J. M. (2010). Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 318, 10-14.
46. Wong, I. P., Zengin, A., Herzog, H. and Baldock, P. A. (2008). Central regulation of bone mass. Semin. Cell Dev. Biol. 19, 452-458.
47. Wu, Z., Xie, Y., Morrison, R. F., Bucher, N. L. and Farmer, S. R. (1998). PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes. J. Clin. Invest. 101, 22-32.
48. Wu, Z., Rosen, E. D., Brun, R., Hauser, S., Adelmant, G., Troy, A. E., McKeon, C., Darlington, G. J. and Spiegelman, B. M. (1999). Cross-regulation of C/EBP alpha and PPAR gamma controls the transcriptional pathway of adipogenesis and insulin sensitivity. Mol. Cell 3, 151-158.
49. Yamamoto, T., Nakahata, Y., Tanaka, M., Yoshida, M., Soma, H., Shinohara, K., Yasuda, A., Mamine, T. and Takumi, T. (2005). Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element. J. Biol. Chem. 280, 42036-42043.
50. Yoshizawa, T., Hinoi, E., Jung, D. Y., Kajimura, D., Ferron, M., Seo, J., Graff, J. M., Kim, J. K. and Karsenty, G. (2009). The transcription factor ATF4 regulates glucose metabolism in mice through its expression in osteoblasts. J. Clin. Invest. 119, 2807-2817.
51. Zenz, R., Eferl, R., Scheinecker, C., Redlich, K., Smolen, J., Schonthaler, H. B., Kenner, L., Tschachler, E. and Wagner, E. F. (2008). Activator protein 1 (Fos/Jun) functions in inflammatory bone and skin disease. Arthritis Res. Ther. 10, 201.